Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06792175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models

Study acronym: MINDAIM
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 3, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation Start date changed from estimate of Feb 2025 to Feb 4, 2025 · Site contacts updated at 2 of 2 sitesv2 Show 2 more changesShow less
    • Start date changed from estimate of Feb 2025 to Feb 4, 2025
    • Site contacts updated at 2 of 2 sites
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Psyrin Inc.
2 trials monitored
See all monitored trials
Depression
2,998 trials monitored
See 166 trials at risk
Anxiety
2,264 trials monitored
See 97 trials at risk
PTSD
821 trials monitored
See 49 trials at risk
and 3 more diseases
This study investigates whether AI-driven analysis of speech can accurately predict clinical diagnoses and assess risk for various mental or behavioral health conditions, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, generalized anxiety disorder, major depressive disorder, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and schizophrenia. We aim to develop tools that can support clinicians in making more accurate and efficient diagnoses.
Trial Details
NCT Number NCT06792175
Lead Sponsor Psyrin Inc.
Collaborators: Allwell Behavioral Health Services, The Brookline Center
Conditions Autism Spectrum Disorder, Depression - Major Depressive Disorder, Anxiety, Generalized, Bipolar Disorder (BD), Attention Deficit Hyperactivity Disorder (ADHD), Schizophrenia Spectrum & Other Psychotic Disorders, Post Traumatic Stress Disorder, Obsessive Compulsive Disorder (OCD)
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov